In this video from Baylor Scott & White Health, watch David P. Mason, M.D., chief of thoracic surgery and lung transplantation, discuss what lung transplantation is, and how it can both extend and improve pulmonary fibrosis and other lung diseases patients’ life. Learn more about…
Pulmonary Fibrosis: Surgical Options for Lung Transplantation
Analysis of pooled data from three international, randomized, and placebo-controlled clinical trails — the Phase 2 TOMORROW trial and two Phase 3 INPULSIS trials — showed that nintedanib (Ofev) is an efficient and safe drug for the treatment of patients with idiopathic pulmonary fibrosis (IPF). The study, “Nintedanib…
Pulmonary Fibrosis Community Resources
Pulmonary Fibrosis Foundation shares a lot of tips on its website about how to deal with your pulmonary fibrosis. One of the things it wants to remind you is to be aware of how and where you search for information about your disease on the internet…
How Old is “Too Old” for a Lung Transplant?
https://www.youtube.com/watch?v=JjH89WbO9js Baylor Scott & White Health shared this video in 2015, where they discussed if and when a person is too old to have a lung transplant. The video features the story of …
In this video from LabTV, shared in 2015, meet Preethi Vijayaraj, “a graduate student in the Gomperts Lab at UCLA”, who is focusing her research into finding a treatment for pulmonary fibrosis and other lung diseases. Learn more about pulmonary fibrosis: https://bit.ly/1VElTQA…
Developing a Research Model For IPF
LabTV shared this video in late 2015, where you can meet Abdo Durra- a research assistant in the Gomperts Lab at UCLA. Durra wants to understand and treat lung diseases, his main purpose being to develop a research model for IPF. Learn more about pulmonary fibrosis: https://bit.ly/1VElTQA…
Researchers discovered that mice exposed to bleomycin — a common pulmonary fibrosis model — displayed more intense fibrotic activity if they lacked the signaling factor PTEN. The findings suggest that exploring the signaling pathway involving PTEN might offer new insights into disease mechanisms, and aid the search for new treatment…
7 Pulmonary Fibrosis Headlines
1. 6 Non-Pharmacological Pulmonary Fibrosis Treatments According to PulmonaryFibrosis.org, there are several types of treatment options to help you with your pulmonary fibrosis. In this article, we’re focusing on bringing you non-pharmacological pulmonary fibrosis treatments. Read more about it: https://bit.ly/1SgrR74 2. …
7 Common Pulmonary Fibrosis Symptoms
Anyone can suffer from pulmonary fibrosis, but it’s more common among middle-aged and older adults. Each patient has an individualized experience with the disease, which means that it can progress faster in some patients than others. As the lung tissue becomes thicker, the lungs lose their ability to properly…
Hyaluronan synthase 2 (HAS2) deletion from fibrotic fibroblasts induces senescence (gradual deterioration) in the cells and fibrotic clearance in mouse models of lung fibrosis. The findings, reported in the study “Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary fibrosis” and published in the journal Matrix Biology, suggest…
Your PF Community
Recent Posts
- When you’re an IPF patient, the costs of care add up, but help is out there January 13, 2026
- Appearances can be deceptive for those living with pulmonary fibrosis January 13, 2026
- Gut bacteria B. adolescentis may be new preventive treatment for PF January 7, 2026
- On my diagnosis journey, I felt like I was moving in slow motion January 6, 2026
- Amid a sea of data, the PF community is critical in the search for a cure December 23, 2025
